LMR Partners »

4d Molecular Therapeutics In shares owned by LMR Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 488k 31.86

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microstrategy Cl A New Put Option (MSTR)
Ishares Tr National Mun Etf Put Option (MUB)
Vaneck Etf Trust Semiconductr Etf (SMH)
Spdr Ser Tr S&p Oilgas Exp Put Option (XOP)
NVIDIA Corporation Put Option (NVDA)
Capri Holdings SHS (CPRI)
Tripadvisor (TRIP)
Microsoft Corporation (MSFT)
BP Sponsored Adr (BP)
Advanced Micro Devices Call Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr China Lg-cap Etf (FXI)
Stellantis SHS Put Option (STLA)

View all positions for LMR Partners

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
VR Adviser
BlackRock
BVF
Henderson Group
Goldman Sachs Group
Viking Global Investors
Vanguard Group
Morgan Stanley
Redmile Group
Arrowpoint Asset Management
Braidwell
FMR
Geode Capital Management
Casdin Capital

View all funds holding 4d Molecular Therapeutics In